智飞生物(300122) - 2014 Q4 - 年度业绩

Financial Performance - Total operating revenue for 2014 reached ¥800,937,517.63, representing a year-on-year increase of 2.66%[3] - Operating profit amounted to ¥170,556,568.50, reflecting a growth of 13.95% compared to the previous year[4] - Net profit attributable to shareholders was ¥146,727,328.04, up by 12.57% year-on-year[4] - Basic earnings per share increased to ¥0.18, a rise of 12.5% from ¥0.16 in the previous year[3] Assets and Equity - Total assets at the end of the reporting period were ¥2,699,008,378.12, an increase of 4.29% from the beginning of the period[3] - Shareholder equity attributable to the company reached ¥2,456,495,369.04, up by 2.81%[3] Marketing and Expenses - The company increased marketing efforts, leading to a rise in sales expenses, which contributed to the net profit growth[5] - The company reported a significant reduction in product expiration losses compared to the previous year[5] Profit Distribution and Audit - The company has not yet discussed the profit distribution for 2014, and specific financial data will be detailed in the annual report[7] - The preliminary financial data is subject to change upon final audit by the accounting firm[2]